News and commentary about white-collar crime, enforcement, and compliance
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Based on total page views, here are the top five posts from the FCPA Blog so far in 2008: 1. Feeling the Heat Overseas, June 9, 2008 Foreign companies can’t be blamed for wondering if they’re being singled out under the Foreign Corrupt Practices Act. The names in the FCPA-related headlines alone are enough to […]
In a recent post, the FCPA Professor questioned the broad application of the label “declination” to any instance of FCPA scrutiny that does not result in an FCPA enforcement action.
Innovative uses of anti-corruption laws to fight terrorists and tyrants and companies that help them is the subject of a breakthrough article published this week by the Wharton School of the University of Pennsylvania.
Here’s a chilling warning to company lawyers who may become involved in FCPA investigations.
For those who missed any of the FCPA enforcement news during the recent hyper-active stretch, here’s what happened: July 28 — Label-maker Avery Dennison Corporation resolved civil and administrative charges brought by the Securities and Exchange Commission. The SEC filed settled enforcement actions in the United States District Court for the Central District of California […]
Label-maker Avery Dennison Corporation, whose compliance problems in China were described in an LA Times story last January, has resolved civil and administrative charges brought by the Securities and Exchange Commission. The SEC filed settled enforcement actions in the United States District Court for the Central District of California charging Avery with violating the FCPA’s […]
Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said Wednesday.
Tungsten, courtesy of Enough Project via YouTubeAn appellate court Monday struck down part of the conflict-minerals rule, leaving SEC-reporting companies wondering what disclosures to include in their conflict minerals reports due on May 31.
The Justice Department on Monday described BAE’s $400 million FCPA-related settlement as one of the biggest ever. Here, by our reckoning, are the other big payouts: Siemens’ $800 million resolution with the DOJ and SEC in December 2008 is the most expensive so far. Kellogg Brown & Root and Halliburton settled their case last year […]
In Canada, Prime Minister Justin Trudeau and his federal Liberal government have been ensnared in a now long-running scandal arising from much publicized allegations that the government, including the Prime Minister himself, improperly attempted to interfere in the ongoing criminal case against SNC-Lavalin, an engineering company based in Quebec — where Liberal support is conveniently the strongest.